Spatial distribution of metabolites in the retina and its relevance to studies of metabolic retinal disorders
-
Published:2023-02-06
Issue:2
Volume:19
Page:
-
ISSN:1573-3890
-
Container-title:Metabolomics
-
language:en
-
Short-container-title:Metabolomics
Author:
Bonelli Roberto,Woods Sasha M.,Lockwood Sarah,Bishop Paul N.,Khan Kamron N.,Bahlo Melanie,Ansell Brendan R. E.,Fruttiger Marcus
Abstract
Abstract
Introduction
The primate retina has evolved regional specialisations for specific visual functions. The macula is specialised towards high acuity vision and is an area that contains an increased density of cone photoreceptors and signal processing neurons. Different regions in the retina display unique susceptibility to pathology, with many retinal diseases primarily affecting the macula.
Objectives
To better understand the properties of different retinal areas we studied the differential distribution of metabolites across the retina.
Methods
We conducted an untargeted metabolomics analysis on full-thickness punches from three different regions (macula, temporal peri-macula and periphery) of healthy primate retina.
Results
Nearly half of all metabolites identified showed differential abundance in at least one comparison between the three regions. Furthermore, mapping metabolomics results from macula-specific eye diseases onto our region-specific metabolite distributions revealed differential abundance defining systemic metabolic dysregulations that were region specific.
Conclusions
The unique metabolic phenotype of different retinal regions is likely due to the differential distribution of different cell types in these regions reflecting the specific metabolic requirements of each cell type. Our results may help to better understand the pathobiology of retinal diseases with region specificity.
Funder
Lowy Medical Research Institute Victorian IRIISS National Health and Medical Research Council
Publisher
Springer Science and Business Media LLC
Subject
Clinical Biochemistry,Biochemistry,Endocrinology, Diabetes and Metabolism
Reference45 articles.
1. Acar, İE., Lores-Motta, L., Colijn, J. M., Meester-Smoor, M. A., Verzijden, T., Cougnard-Gregoire, A., Ajana, S., Merle, B. M. J., de Breuk, A., Heesterbeek, T. J., van den Akker, E., Daha, M. R., Claes, B., Pauleikhoff, D., Hense, H.-W., van Duijn, C. M., Fauser, S., Hoyng, C. B., Delcourt, C., EYE-RISK Consortium. (2020). Integrating metabolomics, genomics, and disease pathways in age-related macular degeneration: The EYE-RISK consortium. Ophthalmology, 127(12), 1693–1709. 2. Anderson, K. J., Borja, M. A., Cotman, C. W., Moffett, J. R., Namboodiri, M. A., & Neale, J. H. (1987). n-acetylaspartylglutamate identified in the rat retinal ganglion cells and their projections in the brain. Brain Research, 411(1), 172–177. 3. Bingol, K. (2018). Recent advances in targeted and untargeted metabolomics by NMR and MS/NMR methods. High-Throughput, 7(2), 9. https://doi.org/10.3390/ht7020009 4. Boesze-Battaglia, K., & Schimmel, R. (1997). Cell membrane lipid composition and distribution: Implications for cell function and lessons learned from photoreceptors and platelets. The Journal of Experimental Biology, 200(Pt 23), 2927–2936. 5. Bone, R. A., Landrum, J. T., Fernandez, L., & Tarsis, S. L. (1988). Analysis of the macular pigment by HPLC: Retinal distribution and age study. Investigative Ophthalmology & Visual Science, 29(6), 843–849.
|
|